Replies to post #117827 on Regen BioPharma Inc (RGBP)

[Valuator2]

So, do you think this 8K is a clear notice (1) that the A/S of Series NC Preferred has increased by another 20,000 to 40,000, or (2) sufficient notice of an authorization of a new Series NC Preferred or (3) a sloppy copy and paste job that contains errors?

I can't see justification for a share price of $.67. JMHO, it has to be something like a slip of a decimal point or an added zero on the number of shares issued in the 8K. $10,050/15,000=$.67.

From the Balance Sheet in the last 10Q:
https://www.otcmarkets.com/filing/html?id=16323310&guid=r0A-k6fOuPKFQth

Series NC Preferred $0.0001 par value 20,000 authorized and 10,000 outstanding as of December 31, 2022 and September 30,2022 respectively